Cargando…
Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)
Persistent infection with the high-risk Human Papillomavirus type 16 (HPV 16) is the causative event for the development of cervical cancer and other malignant tumors of the anogenital tract and of the head and neck. Despite many attempts to develop therapeutic vaccines no candidate has entered late...
Autores principales: | Almajhdi, Fahad N., Senger, Tilo, Amer, Haitham M., Gissmann, Lutz, Öhlschläger, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244082/ https://www.ncbi.nlm.nih.gov/pubmed/25422946 http://dx.doi.org/10.1371/journal.pone.0113461 |
Ejemplares similares
-
Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice
por: Whitehead, Mark, et al.
Publicado: (2014) -
Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model
por: Su, Lin, et al.
Publicado: (2021) -
E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice
por: Viarisio, Daniele, et al.
Publicado: (2011) -
Correction: E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice
por: Viarisio, Daniele, et al.
Publicado: (2016) -
Establishment of immunoassay for detecting HPV16 E6 and E7 RNA
por: Ding, Sen, et al.
Publicado: (2015)